Nvidia may soon unveil a brand-new AI chip. A closer look at the $20 billion bet to make it happen

Nvidia reportedly agreed to a ~$20 billion licensing-and-talent deal with Groq, including hiring Groq founder Jonathan Ross, to accelerate development of inference-focused chips and integrate that technology into Nvidia's AI stack. The move could materially enhance Nvidia's inference competitive position (inference represented ~40% of revenue per 2024 disclosures) and complements its existing GPU and rapidly growing networking business (Q4 fiscal 2026 revenue $68.13B companywide; networking ~$11B in the quarter). Nvidia is expected to outline plans at next week’s GTC, making this a sector-driving strategic development with meaningful implications for data-center customers and competitors.

Analysis

If Nvidia folds a specialist, low-latency inference architecture into its stack, the immediate strategic win is not only performance per watt but a higher-margin product tier that can be sold as an attach to existing GPU deployments. That creates a two-sided commercial lever: sell new inference blades to fresh greenfield customers while monetizing installed GPU bases by offering “nitro” accelerators that increase throughput without full GPU refreshes. Expect this to reshape customer TCO math—shifting the purchase decision from “buy more general-purpose GPUs” to “buy a GPU + targeted accelerators,” which lengthens upgrade cycles for full-GPU replacements and improves lifetime revenue per customer.

Second-order supply effects matter: any shift toward on-die SRAM-centric inference silicon reduces near-term pressure on HBM supply and could relieve a major cost input for training-optimized incumbents. That dynamic favors vendors with networking and systems footprints (who capture incremental attach) over pure-play GPU suppliers. Cloud providers and hyperscalers will run a procurement calculus balancing vendor lock-in, software portability, and unit economics—so early design wins will translate into durable cloud revenue only if the software stack (compilers, model adapters) meaningfully lowers switching cost within 6–18 months.

Downside catalysts are integration risk, customer adoption lag, and regulatory scrutiny of talent/licensing deals; any of these can push full commercial ramp beyond a 12–24 month horizon. Watch three measurable levers as triggers: published sustained performance/Watt for real LLMs, an SDK that reduces porting effort to under 3 engineer-weeks per model, and first major cloud provider procurement contracts; failure on any pushes valuation re-rate risk into the near term.

Key Decisions for Investors

• Long NVDA equity or targeted call spread (buy 6-month ATM calls, sell 6-month 30% OTM calls) sized 2–4% of portfolio — trade the structural premium on differentiated inference + networking attach; target 30–50% upside in 6–12 months, max loss limited to premium paid (expect >20% implied vol compression if product narrative meets expectations).
• Paired trade: long NVDA / short AMD (equal dollar, rebalanced monthly) for 6–12 months — asymmetric capture of inference specialization upside vs. AMD’s GPU training-centric exposure. Risk: AMD wins large cloud deals; cap position to 1–2% net exposure and use a 15% stop-loss on the short leg.
• Long AVGO (or buy 9–12 month call spread) at current levels — play the networking attach tailwind if specialist inference accelerators drive higher fabric throughput and sales of switch/adapter silicon. Reward: 25–40% upside if attach rates rise; risk: macro IT spend pullback within 3 quarters.
• Volatility/cost arbitrage: buy long-dated NVDA LEAP calls (12–18 months) financed by selling 1–2 month calls into product-announcement windows (calendar spread); this captures long-term structural upside while monetizing short-term implied vol spikes. Keep gross exposure limited and close front-month shorts into any confirmed customers/benchmarks to avoid assignment.